| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| P356 | DOI | 10.1161/CIRCRESAHA.116.309045 |
| P698 | PubMed publication ID | 28096194 |
| P2093 | author name string | Matteo Monami | |
| Gian Paolo Fadini | |||
| Mauro Rigato | |||
| P433 | issue | 8 | |
| P921 | main subject | autologous cell therapy | Q107617345 |
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 1326-1340 | |
| P577 | publication date | 2017-01-17 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies | |
| P478 | volume | 120 |
| Q97423824 | Administration of Slow-Release Synthetic Prostacyclin Agonist Promoted Angiogenesis and Skeletal Muscle Regeneration for Limb Ischemia |
| Q55431961 | Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials. |
| Q64270510 | Autologous stem cell therapy for peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials |
| Q49917431 | Cell therapy for peripheral artery disease. |
| Q92997279 | Cell therapy of critical limb ischemia-problems and prospects |
| Q48144378 | Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. |
| Q92970977 | Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus |
| Q89900560 | Development of a two-stage limb ischemia model to better simulate human peripheral artery disease |
| Q55044208 | Efficacy and long-term longitudinal follow-up of bone marrow mesenchymal cell transplantation therapy in a diabetic patient with recurrent lower limb bullosis diabeticorum. |
| Q57162894 | Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology |
| Q52776934 | Getting A Leg Up on Cell Therapy for Critical Limb Ischemia. |
| Q90115248 | Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia |
| Q92810672 | Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy |
| Q92531093 | In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia |
| Q60920493 | Isolation of clinically relevant concentrations of bone marrow mesenchymal stem cells without centrifugation |
| Q57796293 | Lower extremity arterial disease in patients with diabetes: a contemporary narrative review |
| Q98830259 | Mesenchymal Stem Cells Decrease M1/M2 Ratio and Alleviate Inflammation to Improve Limb Ischemia in Mice |
| Q91340862 | PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients |
| Q60912269 | Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia |
| Q58694834 | Protein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseases |
| Q58693006 | Purified CD34 cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial |
| Q98577257 | ROS-responsive capsules engineered from EGCG-Zinc networks improve therapeutic angiogenesis in mouse limb ischemia |
| Q102075372 | Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia |
| Q92712759 | Stem cell therapy in critical limb ischemia: Current scenario and future trends |
| Q58595974 | Stem/Progenitor Cells and Their Therapeutic Application in Cardiovascular Disease |
| Q61804583 | Sufficient therapeutic effect of cryopreserved frozen adipose-derived regenerative cells on burn wounds |
| Q55346713 | The Vasoreparative Function of Myeloid Angiogenic Cells Is Impaired in Diabetes Through the Induction of IL1β. |
| Q90433367 | Thermosensitive, fast gelling, photoluminescent, highly flexible, and degradable hydrogels for stem cell delivery |
| Q92677843 | Tissue Engineering of the Microvasculature |
| Q89927131 | Vascular disease: Cell therapy lowers PAD amputation risk |
| Q89124902 | miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia |
Search more.